Non-small-cell lung cancer: how to manage BRAF-mutated disease
Giorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, Matthew Dankner, April A. N. Rose, Francesco Facchinetti
Abstract
-mutant NSCLC, and an overview of ongoing clinical trials in the peri-operative setting that could open new perspectives in the future.
Topics & Concepts
MedicineOncologyImmunotherapyLung cancerDiseaseRetrospective cohort studyAdenocarcinomaClinical trialInternal medicineTargeted therapyCancerLung Cancer Treatments and MutationsMelanoma and MAPK PathwaysColorectal Cancer Treatments and Studies